Persistence of human parvovirus B19 in tissues from adult individuals: a comparison with serostatus and its clinical utility

Archives of Virology

Volumn 159, Issue 9, 2014, Pages 2371-2376

  Aravindh, R ^a   Saikia, Uma Nahar ^a   Mishra, Baijayantimala ^a   Kumari, Vandana ^a   Sarkar, Subhabrata ^a   Sharma, Mirnalini ^a   Ratho, Radha Kanta ^a   Joshi, Kusum ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute Viral Myocarditis; Asymptomatic Individual; Fulminant Liver Failure; Myocarditis; Proliferative Glomerulonephritis

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; CHILD; FEMALE; HEART; HETEROZYGOTE; HUMAN; HUMAN PARVOVIRUS B19; ISOLATION AND PURIFICATION; KIDNEY; LIVER; MALE; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BONE MARROW; CARRIER STATE; CHILD; FEMALE; HEART; HUMANS; KIDNEY; LIVER; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; YOUNG ADULT;

EID: 84907878911     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-014-2065-8     Document Type: Article

References (31)

1. Abraham M, Rudraraju R, Kannangai R, George K, Cherian T, Daniel D, Ramalingam S, Sridharan G (2002) A pilot study on the seroprevalence of parvovirus PVB19 infection. Indian J Med Res 115:139–143
2. Andersson B, Lindberg E, Lindeqvist JA, Nilsson F, Magnusson Y, Karason K (2008) Parvovirus is a common finding in diseased and healthy myocardium. Eur Heart J 29:148–152
3. Bal A, Mishra B, Singh N, Das A, Jindal SK (2009) Fulminant parvovirus B19 associated with haemophagocytic lympho-histiocytosis in an immunocompetent adult. APMIS 117:773–777
4. Cassinotti P, Bas S, Siegl G, Vischer TL (1995) Association between human parvovirus PVB19 infection and arthritis. Ann Rheum Dis 54:498–500
5. Cohen BJ, Gandhi J, Clewley JP (2006) Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing. J Clin Virol 36:152–155
6. Corcicolli F, Zackerzewska K, Rinieri A, Fanci R (2008) Tissue persistence of parvovirus PVB19 genotypes in asymptomatic patients. J Med Virol 80:2005–2011
7. Cossart YE, Field AM, Cant B, Widdows D (1975) Parvovirus like particles in human sera. Lancet 1:72–73
8. Dina J, Villedieu F, Labombarda F, Freymuth F, de la Gastine G, Jokic M, Vabret A (2010) Childhood myocarditis and parvovirus B19 genotypes. J Clin Virol 50:61–64
9. Eis-Hubinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, Putz U (2001) Evidence for persistence of parvovirus PVB19 DNA in livers of adults. J Med Virol 65:395–401
10. Hillingso JG, Jensen IP, Tom-Petersen L (1998) Parvovirus PVB19 and acute hepatitis in adults. Lancet 351:355–356
11. Ho JK, Tha SP, Coupland R, Dalal BI, Bowie WR, Sreenivasan GM, Krajden M, Yoshida EM (2005) Parvovirus PVB19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol 19:161–162
12. Kuhl U, Paushiinger M, Seebeg B, Lassner D, Noutsias M, Poller W, Schultheiss HP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970
13. Landolsi H, Yacoubi MT, Bouslama M (2009) Detection of human Parvovirus B19 in non-immune hydrops fetalis using immunohistochemistry and nested PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues. Pathologie Biologie 57:e1–e7
14. Langnas AN, Markin RS, Cattral MS, Naides SJ (1995) Parvovirus PVB19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22:1661–1665
15. Lotze U, Egerer R, Tresselt C, Gluck B, Dannberg G, Stelzner A, Figulla HR (2004) Frequent detection of parvovirus PVB19 genome in the myocardium of adult patients with idiopathic DCM. Med Microbiol Immunol 193:75–82
16. Lotze U, Egerer R, Gluck B, Zell R, Sigusch H, Erhardt C (2010) Low level of myocardial parvovirus PVB19 persistence is a frequent finding in patients with heart disease but related to ongoing myocardial injury. J Med Virol 82:1449–1457
17. Mishra B, Malhotra P, Ratho RK, Singh MP, Varma S, Varma N (2005) Human Parvovirus B 19 in patients with aplastic anemia. Am J Haematol 79:166–167
18. Modrow S, Dorsch S (2002) Antibody responses in parvovirus PVB19 infected patients. Pathol Biol 50:326–331
19. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M (2001) Association of parvovirus PVB19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59:2126–2133
20. Naides SJ, Karetnyi YV, Cooling LL, Mark RS, Langnas AN (1996) Human parvovirus PVB19 infection and hepatitis. Lancet 347:1563–1564
21. Ooi L, Hooi S, Chua BH, Lam SK, Chua KB (2005) Seroprevalence of human parvovirus PVB19 infection in an urban population in Malaysia. Med J Malaysia 57:97–103
22. Pankuweit S, Lamparter S, Schoppet M, Maisch B (2004) Parvovirus PVB19 genome in EMB specimen. Circulation 109:179–182
23. Rohrer C, Gartner B, Sauerbrei A, Böhm S, Hottenträger B, Raab U, Thierfelder W, Wutzler P, Modrow S (2008) Seroprevalence of parvovirus PVB19 in the German population. Epidemiol Infect 136:1564–1575
24. Schenk T, Enders M, Pollak S, Hahn R, Huzley D (2009) High prevalence of human parvovirus PVB19 DNA in myocardial autopsy samples from subjects without myocarditis or DCM. J Clin Microbiol 47:106–110
25. Schneider B, Hone A, Tolba RH, Fischer HP, Blümel J, Eis-Hübinger AM (2008) Simultaneous persistence of multiple genome variants of human parvovirus PVB19. J Gen Virol 89:164–176
26. Soderlund M, Von Essen R, Haapasaari J, Kiistala U (1997) Persistence of parvovirus PVB19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349:1063–1065
27. Takahasi T, Ozawa K, Takahasi K, Asano S, Takatu F (1990) Susceptibility of human erythropoietic cells to PVB19 parvovirus in vitro increases with differentiation. Blood 75:603–610
28. Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB (2000) Parvovirus PVB19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 35:1166–1174
29. Wang C, Heim A, Schlaphoff V (2009) Intra hepatic long time persistence Parvovirus B 19 and its role in chronic viral hepatitis. J Med Virol 81:2079–2088
30. Wong S, Young NS, Brown KE (2003) Prevalence of parvovirus PVB19 in liver tissue: no association with fulminant hepatitis or hepatitis- associated aplastic anemia. J Infect Dis 187:1581–1586
31. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S (1996) Human parvovirus PVB19 infection associated with acute hepatitis. Lancet 347:868–869